Clinical evaluation of Kagamaasi thylam ( A siddha drug) in the management of childhood asthma (sooli kanam)
Phase 2
Completed
- Conditions
- Health Condition 1: J459- Other and unspecified asthma
- Registration Number
- CTRI/2021/08/035372
- Lead Sponsor
- OPD and IPD Ayothidoss Pandithar Hospital National instititue of siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Children with any of the symptoms such as
Cough
Wheezing
Shortness of breath
Abdominal bloating
Tightness of chest
Loss of appetite are included
Exclusion Criteria
K/H/o
Hemoptysis
Active primary complex
Congenital heart disease
Pneumonia
Status asthmaticus
Any other chronic illness are excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of the trail drug is measured by peak expiratory flow meter <br/ ><br>Improvement in the clinical symptoms by using PASS scoreTimepoint: 45 days
- Secondary Outcome Measures
Name Time Method Reduction in the recurrence of the disease and improvement in the quality of life of childrenTimepoint: Before and after treatment